Publicaciones en colaboración con investigadores/as de Centro de Investigación y de Estudios Avanzados (13)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Clinical Phenotypes and Mortality Biomarkers: A Study Focused on COVID-19 Patients with Neurological Diseases in Intensive Care Units

    Behavioral Sciences, Vol. 12, Núm. 7

2020

  1. New Aspects of VEGF, GABA, and Glutamate Signaling in the Neocortex of Human Temporal Lobe Pharmacoresistant Epilepsy Revealed by RT-qPCR Arrays

    Journal of Molecular Neuroscience, Vol. 70, Núm. 6, pp. 916-929

  2. Pathophysiological mechanisms that trigger neuronal death in drug-resistant temporal lobe epilepsy

    Anales de la Academia de Ciencias de Cuba, Vol. 10, Núm. 3

2016

  1. Oxidative stress in pharmacoresistant epilepsy

    Biotecnologia Aplicada, Vol. 33, Núm. 2, pp. 2101-2107

2013

  1. Excitotoxicidad y muerte neuronal en la epilepsia

    Biotecnologia Aplicada, Vol. 30, Núm. 1, pp. 1-8

  2. Inflammatory mediators in epilepsy

    Current Pharmaceutical Design, Vol. 19, Núm. 38, pp. 6766-6772

  3. Mecanismos de neurodegeneración en la epilepsia del lóbulo temporal

    Revista Chilena de Neuro-Psiquiatria, Vol. 51, Núm. 2, pp. 137-148

  4. Pharmacoresistant epilepsy and immune system

    Pharmacoresistance in Epilepsy: From Genes and Molecules to Promising Therapies (Springer New York), pp. 149-168

  5. Transcranial magnetic stimulation and refractory partial epilepsy

    Pharmacoresistance in Epilepsy: From Genes and Molecules to Promising Therapies (Springer New York), pp. 265-289

2009

  1. Microscopic mild focal cortical dysplasia in temporal lobe dual pathology: An electrocorticography study

    Seizure, Vol. 18, Núm. 8, pp. 593-600

2008

  1. Muerte neuronal en la neocorteza de pacientes con epilepsia del lóbulo temporal resistente a fármacos

    Neurologia, Vol. 23, Núm. 9, pp. 555-565

2007

  1. Autoradiography reveals selective changes in serotonin binding in neocortex of patients with temporal lobe epilepsy

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 31, Núm. 6, pp. 1208-1218